Effects of BPA Substitutes

Two studies add to the evidence that replacements for the plastic additive affect cells and animals in the same, untoward ways as bisphenol A.

Written byKerry Grens
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Bisphenol SWIKIMEDIA, ROLAND1952Bisphenol A (BPA), a plastics ingredient, is generally recognized as an endocrine disruptor, and concerns over its potential impact on human health have prompted manufacturers to eliminate it from some consumer products. A few nations have even implemented partial bans on how the chemical can be used, and last year, France went to far as to ban BPA from food packaging altogether. Yet “BPA-free” does not necessarily mean free of all bisphenols—and as a pair of recent studies show, substitutes for BPA affect cells and animals in much the same ways.

It’s hard to get a handle on all the chemicals present in plastic products, no less so in items labeled BPA-free. The presumption is that at least some BPA-free items contain a BPA analog—such as bisphenol S or F (BPS, BPF)—as a replacement, and a 2012 study including more than 300 volunteers found BPS in 81 percent of urine samples.

But compared to BPA, there have been far fewer studies on related bisphenols, prompting a number of groups to compare the cellular and physiological effects of these chemicals. Most recently, Pascal Coumailleau of INSERM’s Research Institute for Environmental and Occupational Health and the University of Rennes in France and colleagues measured the effects of four bisphenols on the brains of zebrafish.

Exposing the animals to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies